Published in Cancer Weekly, May 5th, 2009
"Our initial studies found that some Gemini analogues are 5-15 times more active than 1 alpha,25(OH)(2)D-3 in growth inhibition assay. In...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.